Faron Pharmaceuticals Oy (LON:FARN – Get Free Report)’s share price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 44.03 and traded as low as GBX 40. Faron Pharmaceuticals Oy shares last traded at GBX 42.50, with a volume of 27,256 shares traded.
Faron Pharmaceuticals Oy Price Performance
The company has a quick ratio of 1.09, a current ratio of 0.84 and a debt-to-equity ratio of -133.35. The firm has a market cap of £84.79 million, a P/E ratio of -1.93 and a beta of 1.11. The business has a fifty day moving average of GBX 44.03 and a 200 day moving average of GBX 113.37.
About Faron Pharmaceuticals Oy
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Featured Stories
- Five stocks we like better than Faron Pharmaceuticals Oy
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
